As of 2025-07-08, the Relative Valuation of Kinnate Biopharma Inc (KNTE) is (50.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.65 USD, the upside of Kinnate Biopharma Inc based on Relative Valuation is -2015.0%.
The range of the Relative Valuation is (32.00) - (63.52) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 26.6x | 19.8x |
| Forward P/E multiples | 13.4x - 32.1x | 22.8x |
| Fair Price | (32.00) - (63.52) | (50.75) |
| Upside | -1307.6% - -2497.1% | -2015.0% |
| Date | P/E |